Agilent Technologies +

Company

Ticker

TMO

DHR

Headquarter

Santa Clara ,CA

Waltham ,MA

Washington ,DC

CEO

Padraig McDonnell

Marc N. Casper

Rainer M. Blair

Industry

Medical - Diagnostics & Research

Stock Price

Market Cap

$32.56 B

$173.97 B

$143.61 B

Employees

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Employees

18.10 K
18.10 K
17.90 K

130.00 K
122.00 K
125.00 K

81.00 K
63.00 K
63.00 K

Y/Y

6.47%

1.1%

6.15%

2.46%

1.25%

22.22%

Income Statement

Revenue

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Revenue

$6.85 B
$6.83 B
$6.51 B

$44.92 B
$42.86 B
$42.88 B

$26.64 B
$23.89 B
$23.88 B

Y/Y

8.37%

0.22%

4.73%

14.55%

4.58%

0.05%

9.54%

10.33%

0.06%

Revenue by Products / Services

Revenue by Geography

Research and Development

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Research and Development

$467.00 M
$481.00 M
$479.00 M

$1.47 B
$1.34 B
$1.39 B

$1.53 B
$1.50 B
$1.58 B

Y/Y

5.9%

0.42%

4.62%

9.11%

3.96%

12.28%

1.64%

5.39%

Operating Income

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Operating Income

$1.62 B
$1.35 B
$1.49 B

$8.53 B
$7.45 B
$7.66 B

$7.54 B
$5.28 B
$5.18 B

Y/Y

20.12%

16.56%

10.22%

17.38%

12.66%

2.9%

6.39%

29.95%

1.8%

Tax Rate (%)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Tax Rate (%)

17.00%
7.00%
15.00%

9.00%
5.00%
9.00%

13.00%
16.00%
16.00%

Y/Y

50.68%

55.54%

106.36%

26.93%

50.38%

106.37%

20.66%

24.96%

1.47%

Net Income

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Net Income

$1.25 B
$1.24 B
$1.29 B

$6.95 B
$6.00 B
$6.34 B

$7.21 B
$4.76 B
$3.90 B

Y/Y

3.64%

1.12%

3.95%

10.03%

13.74%

5.67%

12.06%

33.92%

18.16%

Revenue Per Employee

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Revenue Per Employee

$378.34 K
$377.51 K
$363.69 K

$345.50 K
$351.29 K
$343.03 K

$328.93 K
$379.21 K
$378.97 K

Y/Y

1.79%

0.22%

3.66%

14.55%

1.67%

2.35%

10.66%

15.29%

0.06%

Net Income Per Employee

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Net Income Per Employee

$69.28 K
$68.51 K
$72.01 K

$53.46 K
$49.14 K
$50.68 K

$89.00 K
$75.62 K
$61.89 K

Y/Y

2.66%

1.12%

5.11%

10.03%

8.08%

3.14%

10.68%

15.03%

18.16%

Assets & Liabilities | Cash Flow

Total Assets

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Total Assets

$10.53 B
$10.76 B
$11.85 B

$97.15 B
$98.73 B
$97.32 B

$84.35 B
$84.49 B
$77.54 B

Y/Y

1.62%

2.19%

10.06%

2.14%

1.62%

1.42%

1.4%

0.16%

8.22%

Total Liabilities

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Total Liabilities

$5.23 B
$4.92 B
$5.95 B

$53.01 B
$51.88 B
$47.65 B

$34.26 B
$31.00 B
$27.99 B

Y/Y

1.67%

5.91%

20.94%

2.11%

2.12%

8.16%

9.86%

9.52%

9.7%

Capital Expenditures (Capex)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Capital Expenditures (Capex)

-$291.00 M
-$298.00 M
-$378.00 M

-$2.24 B
-$1.48 B
-$1.40 B

-$1.15 B
-$1.38 B
-$1.39 B

Y/Y

53.97%

2.41%

26.85%

11.1%

34.06%

5.34%

10.97%

20.05%

0.65%

Profitability

Operating Income Margin (%)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Operating Income Margin (%)

23.63%
19.76%
22.86%

18.98%
17.37%
17.87%

28.29%
22.10%
21.71%

Y/Y

10.83%

16.38%

15.69%

27.86%

8.48%

2.88%

3.51%

21.88%

1.76%

Net Income Margin (%)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Net Income Margin (%)

18.31%
18.15%
19.80%

15.47%
13.99%
14.77%

27.06%
19.94%
16.33%

Y/Y

4.39%

0.87%

9.09%

21.47%

9.57%

5.58%

23.9%

26.31%

18.1%

EBITDA

2021	1762000000.00
2022	1905000000.00
2023	1703000000.00
2024	1874000000.00

2021	11969000000.00
2022	11942000000.00
2023	11195000000.00
2024	11800000000.00

2021	10007000000.00
2022	9485000000.00
2023	7499000000.00
2024	7276000000.00

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

EBITDA

$1.91 B
$1.70 B
$1.87 B

$11.94 B
$11.20 B
$11.80 B

$9.49 B
$7.50 B
$7.28 B

Y/Y

8.12%

10.6%

10.04%

0.23%

6.26%

5.4%

5.22%

20.94%

2.97%

Free Cash Flow (FCF)

2021	1296000000.00
2022	1021000000.00
2023	1474000000.00
2024	1373000000.00

2021	7020000000.00
2022	6911000000.00
2023	6927000000.00
2024	7267000000.00

2021	7064000000.00
2022	7367000000.00
2023	5781000000.00
2024	5296000000.00

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Free Cash Flow (FCF)

$1.02 B
$1.47 B
$1.37 B

$6.91 B
$6.93 B
$7.27 B

$7.37 B
$5.78 B
$5.30 B

Y/Y

21.22%

44.37%

6.85%

1.55%

0.23%

4.91%

4.29%

21.53%

8.39%

Ratios

Return on Equity (ROE)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Return on Equity (ROE)

23.64%
21.21%
21.85%

15.80%
12.83%
12.78%

14.39%
8.91%
7.87%

Y/Y

5.3%

10.28%

3.02%

16.58%

18.8%

0.39%

1.05%

38.08%

11.67%

Return on Assets (ROA)

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Return on Assets (ROA)

11.91%
11.52%
10.88%

7.15%
6.07%
6.51%

8.55%
5.64%
5.03%

Y/Y

5.4%

3.27%

5.56%

11.95%

15.1%

7.25%

10.61%

34.04%

10.82%

Debt to Equity

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Debt to Equity

55.06%
49.60%
57.48%

82.03%
77.94%
66.10%

39.29%
36.53%
32.31%

Y/Y

1.93%

9.92%

15.89%

7.91%

4.99%

15.19%

19.98%

7.02%

11.55%

Valuation

Enterprise Value

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Enterprise value

$43.23 B
$31.70 B
$39.85 B

$243.42 B
$233.23 B
$227.49 B

$184.28 B
$184.05 B
$181.73 B

Y/Y

12.08%

26.68%

25.71%

17.42%

4.19%

2.46%

19.17%

0.12%

1.26%

Enterprise value to Revenue

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Enterprise value to Revenue

6.31
4.64
6.12

5.42
5.44
5.31

5.86
7.70
7.61

Y/Y

18.87%

26.52%

31.95%

27.9%

0.41%

2.51%

24.36%

31.57%

1.2%

Enterprise value to EBITDA

Years

2022
2023
2024

2022
2023
2024

2022
2023
2024

Enterprise value to EBITDA

22.70
18.61
21.27

20.38
20.83
19.28

18.97
24.54
24.98

Y/Y

18.68%

17.98%

14.24%

17.23%

2.21%

7.46%

16.72%

29.35%

1.76%

Agilent Technologies Competitors & Alternatives

Income Statement

Assets & Liabilities | Cash Flow

Profitability

Ratios

Valuation

Related company

Submit feedback to Bullfincher